Differentiation syndrome with lethal lung injury after arsenic trioxide treatment for myelodysplastic syndrome

Am J Hematol. 2007 Apr;82(4):332-3. doi: 10.1002/ajh.20773.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Arsenic Trioxide
  • Arsenicals / adverse effects*
  • Arsenicals / therapeutic use
  • Cell Differentiation / drug effects
  • Humans
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / drug therapy*
  • Oxides / adverse effects*
  • Oxides / therapeutic use
  • Pulmonary Alveoli / drug effects
  • Pulmonary Alveoli / pathology
  • Respiratory Distress Syndrome / chemically induced*
  • Syndrome

Substances

  • Antineoplastic Agents
  • Arsenicals
  • Oxides
  • Arsenic Trioxide